Gilead, Vertex initiated as new big biotech buys at Citi
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
Hosted on MSN5h
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Gilead Sciences (GILD) has been one of the most searched-for stocks ... During this period, the Zacks Medical - Biomedical and Genetics industry, which Gilead falls in, has lost 1.9%. The key question ...
Hosted on MSN1d
Gilead reports positive HIV PrEP data for lenacapavir
Gilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...
pharmaphorum20h
FDA clears first DTx for depression from Otsuka, Click
Rejoyn (formerly CT-152), a software-as-a-medical device (SaMD) delivered via a smartphone app, has been authorised as an add-on to clinician-managed outpatient care for adults aged 22 and over ...
Nature20h
Earth and environmental sciences articles from across Nature Portfolio
Earth and environmental sciences cover all aspects of Earth and planetary sciences, and broadly encompasses solid Earth processes, surface and atmospheric dynamics, Earth system history ...
Saint Louis University20h
Saint Louis University School of Medicine
Saint Louis University's School of Medicine has a long tradition of excellence in medical school, graduate medical education and graduate education. Established in 1836, the school has the distinction ...
pharmaphorum20h
Understanding PDURS: A new era for digital health and pharma
A potential workaround to existing restrictions such as anti-kickback laws and rigorous drug-device combination approvals, the PDURS framework allows pharmaceutical manufacturers to add software ...